Single-Use Systems (SUS) Validation: Integrity Testing & Extractables/Leachables (E&L)
Single-Use Systems (SUS)—including bioprocess bags, tubing assemblies, sterile connectors, and single-use filling needles—have transformed biopharmaceutical manufacturing. However, regulatory expectations under EU GMP Annex 1 and FDA guidance mandate rigorous qualification of SUS integrity, point-of-use leak testing, and toxicological evaluation of Extractables and Leachables (E&L).
In This Guide
- 1. SUS Implementation and Regulatory Expectations
- 2. Extractables vs. Leachables Framework
- 3. Point-of-Use Integrity Testing Methods
- 4. Analytical Evaluation Threshold (AET) Calculator
- 5. Common Single-Use Qualification Vulnerabilities
- 6. SUS Implementation Audit Readiness Checklist
- 7. Practical E&L Risk Assessment Template
1. SUS Implementation and Regulatory Expectations
While single-use equipment eliminates Cleaning Validation (CIP/SIP) and reduces cross-contamination risks, it introduces unique mechanical and chemical challenges. Annex 1 Clause 8.118 requires that single-use systems be designed to withstand integrity stresses during transport, installation, and operation.
Manufacturers must verify that gamma irradiation doses (typically 25–45 kGy) do not compromise polymer stability, generate particulate matter, or cause excessive polymer degradation that could leech into formulation streams.
Single-Use Technology in Biopharmaceutical Manufacturing
Comprehensive coverage of polymer characterization, integrity testing, sterile connection qualification, and extractables risk evaluation.
Find it on Amazon →2. Extractables vs. Leachables Framework
| Parameter | Extractables (E) | Leachables (L) |
|---|---|---|
| Definition | Chemical entities forced out of polymer matrices using aggressive solvents under exaggerated temperature and time conditions. | Chemical compounds that migrate spontaneously from SUS components into drug product formulation under real storage conditions. |
| Testing Conditions | Accelerated/Exaggerated (Ethanol/Water, high temp, 24–72 hours). | Actual drug product contact time, shelf-life temperature, real pH. |
| Primary Goal | Establish a material "fingerprint" and worst-case impurity library. | Evaluate patient toxicological safety and drug substance stability. |
| Key Standards | BPOG (Biophorum Operations Group) & USP <665> / <1665>. | USP <664> & PQRI (Product Quality Research Institute) guidelines. |
3. Point-of-Use Integrity Testing Methods
Visual inspection alone cannot detect pinhole leaks (< 10 µm) in flexible film assemblies. Revised regulatory guidelines strongly recommend pressure decay or helium tracer gas integrity testing prior to filling critical sterile solutions.
- Pressure Decay Testing: Measures pressure drop over time inside a pressurized bag assembly held within a restraining plate fixture. Detects leaks down to 10–20 µm.
- Helium Tracer Gas Leak Detection: Uses vacuum chambers to measure helium migration through microscopic defects. Highly sensitive (detects flaws down to 0.2–2 µm).
- Liquid Barrier / Headspace Gas Analysis: Evaluates closed single-use final containers post-filling.
4. Analytical Evaluation Threshold (AET) Calculator
The Analytical Evaluation Threshold (AET) is the chemical concentration limit above which an unknown leachable compound must be identified and evaluated for toxicological safety.
Extractables & Leachables AET Estimator
5. Common Single-Use Qualification Vulnerabilities
Key Audit Risks in SUS Management
- Relying Solely on Vendor Certificates: Accepting supplier Extractable data without performing product-specific risk assessments (USP <665> matrix evaluation).
- Inadequate Restraining Plate Fixturing: Performing pressure decay testing on bioprocess bags without restraining plates, causing bag expansion and masking real leaks.
- Ignoring Particle Generation during Peristaltic Pumping: Failing to evaluate spallation particles generated by silicone or TPE tubing inside peristaltic fill pumps.
- Unqualified Tube Welding / Sealing: Lacking parameter validation for thermal tube welders and crimpers used in Grade A/B suites.
6. SUS Implementation Audit Readiness Checklist
Single-Use Systems Audit Readiness Checklist
7. Practical E&L Risk Assessment Template
SUS Component Toxicological Evaluation Matrix
| Component Description | Contact Material | Contact Duration & Temp | Extraction Solvent Used | Primary Extractables Detected | PDE Limit (µg/day) | Safety Evaluation Status |
|---|---|---|---|---|---|---|
| 200L Bioprocess Bag | Multilayer PE / EVOH film | 14 days @ 2–8°C | 50% Ethanol / Water | bHT degradation products, Palmitic Acid | 150 µg/day | Complies (Calculated exposure < 5% PDE) |
| Fill Line Tubing | Platinum-cured Silicone | 24 hrs @ 20°C | Purified Water / Low pH buffer | Siloxane oligomers (D4, D5) | 1,000 µg/day | Complies (Below AET) |
| Sterile Disconnectors | Polycarbonate / Polysulfone | 2 hrs @ 20°C | Water for Injection | Bisphenol A (trace) | 5 µg/day | Complies (Toxicological risk acceptable) |
References
- USP General Chapter <665> – Plastic Components and Systems Used in the Manufacturing of Pharmaceutical Drug Products and Biopharmaceutical Drug Substances.
- BPOG Extractables Testing User Guide – Standardized Extractables Testing Protocol for Single-Use Systems in Biomanufacturing.
- EudraLex Volume 4, Annex 1 – Clause 8.117–8.120: Single-Use Systems (SUS).
Disclaimers & Disclosures
Regulatory Disclaimer: This guide is intended strictly for educational and training purposes. Toxicological safety thresholds and integrity test limits must be established based on specific product chemistry and regulatory filings.
Affiliate Disclosure: Contains affiliate links supporting content publication.
No comments:
Post a Comment